Edition:
India

NanoCarrier Co Ltd (4571.T)

4571.T on Tokyo Stock Exchange

511JPY
7:25am IST
Change (% chg)

¥-16 (-3.04%)
Prev Close
¥527
Open
¥523
Day's High
¥526
Day's Low
¥510
Volume
244,600
Avg. Vol
670,227
52-wk High
¥1,337
52-wk Low
¥510

Chart for

About

NanoCarrier Co., Ltd. is a Japan-based biopharmaceutical products developer. The Company develops biopharmaceutical products focused on the medication of cancer and other intractable diseases. It is engaged in the research, development, manufacture, and sale of anti-cancer drugs based on micellar nanoparticle technology. The... (more)

Overall

Beta: 2.65
Market Cap(Mil.): ¥28,727.59
Shares Outstanding(Mil.): 43.20
Dividend: --
Yield (%): --

Financials

BRIEF-NanoCarrier says business and capital alliance with Gene Techno Science and Noritsu Koki

* Says it plans business and capital alliance with Gene Techno Science Co Ltd and Noritsu Koki Co Ltd, regarding biopharmaceutical related business

09 Apr 2018

BRIEF-VBL Therapeutics Receives Milestone Payment From Nanocarrier Under Licensing Agreement For VB-111 In Japan

* VBL THERAPEUTICS RECEIVES MILESTONE PAYMENT FROM NANOCARRIER UNDER LICENSING AGREEMENT FOR VB-111 IN JAPAN

08 Feb 2018

BRIEF-NanoCarrier starts to discuss business alliance with Ceolia Pharma

* Says it starts to discuss business alliance with Ceolia Pharma Co., Ltd., and will cooperate on sale, manufacture and development of pharmaceuticals

17 Jan 2018

Earnings vs. Estimates